BrainCheck Opens New York City Office to Support Northeast Growth

Audio By Carbonatix

AUSTIN, Texas & NEW YORK--(BUSINESS WIRE)--Jan 5, 2026--

BrainCheck, a leading digital cognitive assessment and care platform, today announced the opening of its new East Coast office at 325 Hudson Street in New York City.

The New York office will serve as BrainCheck’s Northeast hub, supporting growing demand from health systems, academic medical centers, specialty practices, and research organizations across the region. The expansion reflects continued momentum as healthcare organizations increasingly adopt digital tools for objective cognitive assessment and longitudinal cognitive care.

BrainCheck is currently used by leading clinical and academic institutions nationwide, including Cleveland Clinic, Stanford University, MD Anderson Cancer Center, Mount Sinai Health System, UPMC, the University of Texas at Austin, Oregon Health & Science University, the University of Colorado Anschutz Medical Campus, Springfield Clinic, and Dent Neurologic Institute, among many others. These partnerships span neurology, psychiatry, primary care, and research settings.

“New York is a critical center for healthcare delivery, academic medicine, and life sciences,” said Chris Loughlin, CEO of BrainCheck. “Establishing a dedicated presence in the Northeast allows us to better support our customers, deepen partnerships with leading institutions, and accelerate growth in a region that is shaping the future of cognitive care.”

BrainCheck’s platform includes its FDA Class II digital cognitive assessment, BrainCheck Assess™, along with more than 20 validated cognitive and behavioral screeners and digital care planning tools. The platform is designed to support early detection, standardized assessment, and ongoing monitoring of cognitive health across diverse care environments.

The New York office complements BrainCheck’s headquarters in Austin, Texas, and aligns with the company’s broader strategy to expand its national footprint while remaining closely connected to customers and clinical partners.

For more information, visit www.braincheck.com.

About BrainCheck

BrainCheck is an FDA Class II–cleared digital platform for cognitive assessment and care, used by over 500 healthcare organizations nationwide, including Bon Secours, UPMC, and Springfield Clinic. Clinicians use BrainCheck’s validated screeners and care planning tools to create tailored protocols, completing more than 400,000 cognitive assessments to date. BrainCheck is not intended for use as a stand-alone diagnostic tool.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260105234477/en/

CONTACT: Media Contact

Kate Smith

Senior Marketing Specialist

BrainCheck Inc

[email protected]

KEYWORD: TEXAS NEW YORK UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: FDA GENERAL HEALTH HEALTH MENTAL HEALTH

SOURCE: BrainCheck

Copyright Business Wire 2025.

PUB: 01/05/2026 09:04 AM/DISC: 01/05/2026 09:04 AM

http://www.businesswire.com/news/home/20260105234477/en